18F-FDG, 68Ga-DOTATATE and 68Ga-PSMA Positive Metastatic Large Cell Neuroendocrine Prostate Tumor-Reference-Cited by-同舟云学术

18F-FDG, 68Ga-DOTATATE and 68Ga-PSMA Positive Metastatic Large Cell Neuroendocrine Prostate Tumor

Published:2019-01 Issue:1 Volume:44 Page:53-54
ISSN:1536-0229
Container-title:Clinical Nuclear Medicine
language:en
Short-container-title:Clin Nucl Med

Author:

Acar Emine,Kaya Gamze Çapa

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Reference8 articles.

1. Neuroendocrine tumors of the prostate: emerging insights from molecular data and updates to the 2016 World Health Organization Classification;Endocr Pathol,2016

2. De novo large cell neuroendocrine carcinoma of the prostate gland with pelvic lymph node metastasis: a case report with review of literature;Int J Clin Exp Pathol,2014

3. Utility of FDG-PET in clinical neuroendocrine prostate cancer;Prostate,2014

4. FDG PET-CT demonstration of metastatic neuroendocrine tumor of prostate;World J Surg Oncol,2008

5. Adenocarcinoma prostate with neuroendocrine differentiation: potential utility of 18F-FDG PET/CT and 68Ga-DOTANOC PET/CT over 68Ga-PSMA PET/CT;Clin Nucl Med,2018

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiolabeled Somatostatin Analogs for Cancer Imaging;Seminars in Nuclear Medicine;2024-08

2. Systemic metastases in large cell neuroendocrine prostate cancer: a rare case report and literature review;Frontiers in Oncology;2024-05-15

3. A systematic review of primary large cell neuroendocrine carcinoma of the prostate;Frontiers in Oncology;2024-03-07

4. Cerebral and Muscular Metastases From Prostate Adenocarcinoma Initially Depicted by 177Lu-PSMA SPECT/CT;Clinical Nuclear Medicine;2024-01-24

5. Innovation in Radionuclide Therapy for the Treatment of Prostate Cancers: Radiochemical Perspective and Recent Therapeutic Practices;Cancers;2023-06-10